Hospital readmissions for decompensated cirrhosis
Michael L. Volk – 20 January 2015 – Watch a video presentation of this article
Replay
Chunping Wang, Ke‐Qin Hu, Yongping Yang – 20 January 2015
Valproic acid‐induced hepatotoxicity in alpers syndrome is associated with mitochondrial permeability transition pore opening‐dependent apoptotic sensitivity in an induced pluripotent stem cell model
Shengbiao Li, Jingyi Guo, Zhongfu Ying, Shen Chen, Liang Yang, Keshi Chen, Qi Long, Dajiang Qin, Duanqing Pei, Xingguo Liu – 20 January 2015 – Valproic acid (VPA) is widely used to treat epilepsy, migraine, chronic headache, bipolar disorder, and as adjuvant chemotherapy, but potentially causes idiosyncratic liver injury. Alpers‐Huttenlocher syndrome (AHS), a neurometabolic disorder caused by mutations in mitochondrial DNA polymerase gamma (POLG), is associated with an increased risk of developing fatal VPA hepatotoxicity.
Randomized, controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma
Myung Han Hyun, Sang Mi Chung – 20 January 2015
Quality of care assessment in chronic liver disease
Fasiha Kanwal – 20 January 2015 – Watch a video presentation of this article
Quality of care assessment in chronic liver disease
Fasiha Kanwal – 20 January 2015 – Watch a video presentation of this article
Risk factors for cytomegalovirus reactivation after liver transplantation: Can pre‐transplant cytomegalovirus antibody titers predict outcome?
Jackrapong Bruminhent, Charat Thongprayoon, Ross A. Dierkhising, Walter K. Kremers, Elitza S. Theel, Raymund R. Razonable – 17 January 2015 – Despite preexisting cytomegalovirus (CMV) immunity, CMV‐seropositive liver transplantation (LT) patients remain at risk of CMV infection. We hypothesized that the pre‐transplant CMV antibody titer correlates with the risk of CMV reactivation. We conducted a retrospective study of CMV‐seropositive LT recipients who did not receive anti‐CMV prophylaxis from 2007 to 2013.
Use of model for end‐stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation
Richard C. Maduka, Peter L. Abt, David S. Goldberg – 17 January 2015 – Donation after cardiac death (DCD) liver transplantation is associated with increased biliary complications and graft failure. Yet for unclear reasons, DCD recipients relisted for transplantation have lower wait‐list mortality than other retransplant candidates.
Hepatology highlights
Jean‐François Dufour – 16 January 2015
A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome
Mark W. Sonderup, Helen Wainwright, Pauline Hall, Henry Hairwadzi, C. Wendy N. Spearman – 16 January 2015 – Liver disease complicates human immunodeficiency virus (HIV)/acquired immune deficiency syndrome; however, liver pathology data are limited, particularly from high HIV prevalence countries. We investigated the spectrum and clinicopathological correlates of liver pathology in a high HIV burden setting.